GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 194 filers reported holding GW PHARMACEUTICALS PLC in Q1 2018. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $9,000 | +80.0% | 40 | 0.0% | 0.00% | +50.0% |
| Q4 2020 | $5,000 | +25.0% | 40 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $4,000 | 0.0% | 40 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $4,000 | +33.3% | 40 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $3,000 | -25.0% | 40 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $4,000 | -60.0% | 40 | -55.6% | 0.00% | -60.0% |
| Q3 2019 | $10,000 | -69.7% | 90 | -52.6% | 0.01% | -70.6% |
| Q2 2019 | $33,000 | +3.1% | 190 | 0.0% | 0.02% | +6.2% |
| Q1 2019 | $32,000 | +77.8% | 190 | 0.0% | 0.02% | +45.5% |
| Q4 2018 | $18,000 | -45.5% | 190 | 0.0% | 0.01% | -35.3% |
| Q3 2018 | $33,000 | +26.9% | 190 | 0.0% | 0.02% | +13.3% |
| Q2 2018 | $26,000 | +62.5% | 190 | +35.7% | 0.02% | +50.0% |
| Q1 2018 | $16,000 | -11.1% | 140 | 0.0% | 0.01% | -9.1% |
| Q4 2017 | $18,000 | +350.0% | 140 | +250.0% | 0.01% | +266.7% |
| Q3 2017 | $4,000 | 0.0% | 40 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $4,000 | -20.0% | 40 | 0.0% | 0.00% | -25.0% |
| Q1 2017 | $5,000 | +25.0% | 40 | 0.0% | 0.00% | +33.3% |
| Q4 2016 | $4,000 | – | 40 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|